Drug Trial Radar · NCT00867516
Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis
Last checked: Nov 20, 2026Latest source record: Jul 9, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
127
Actual
Start
Oct 2008
Primary completion
Jun 2009
Study completion Dec 2009
Sponsor
- Lead sponsor
- CSL BehringIndustry
- Sponsor type
- Industry
- First posted
- Mar 23, 2009
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the safety and efficacy of ALD518 in three different doses in patients who have not had an adequate response to methotrexate.
Conditions
- Arthritis, Rheumatoid
Interventions
ALD518Biological
Two doses of ALD518, each given in an infusion of normal saline, IV over 1 hour, at Weeks 1 and 8
Infusion without ALD518'Biological
250 cc Normal saline IV over one hour Weeks 1 and 8.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and severity of AEs and SAEs during the studyTime frame: During entire length of study
Locations
26 sites in 6 countries. Site status is shown where the registry gives one.
K-W Musculoskeletal Research, Inc.
Kitchener, Ontario, Canada
Rheumatology Research Associates
Ottawa, Ontario, Canada
V. Tsitlanadze Scientific Practical Centre of Rheumatology
Tbilisi, Georgia
Medulla Chemotherapy and Immunotherapy Clinic
Tbilisi, Georgia
St. John's Medical College Hospital
Bangalore, India
Krishna Institute of Medical Sciences Ltd.
Secunderabad, India
Chanre Rheumatology and Immunology Center and Research
Malleshwaram, Bangalore, India
KLE Society Hospital and Medical Research Centre
Nehru Nagar, Belgaum, India
Sushrut Hospital, Research Centre & Post Graduate Institute of Orthopaedics
Ramadaspeth, Nagpur, India
Miriada Center Private Clinic of Professor Sierakowski
Bialystok, Poland
Nonpublic Centre of Medical Care Reumed
Lublin, Poland
NOVAMED - Medical Center of Poznan
Poznan, Poland
Provincional Rheumatological Complex named after Dr Jadwiga Titz-Kosko
Sopot, Poland
Szezecin Clinic of Rheumatology and Internal Diseases
Szczecin, Poland
Regional Clinical Hospital of War Veterans
Kemerovo, Russia
Institute of Clinical and Experimental Lymphology
Novosibirsk, Russia
Ryazan Regional Clinical Cardiologic Dispensary
Ryazan, Russia
Saint Petersburg Medical Academy of Postgraduate Study
Saint Petersburg, Russia
Saint-Petersburg State Medical Academy named after I. I. Mechnikov
Saint Petersburg, Russia
City Hospital #26
Saint Petersburg, Russia
Regional War Veterans' Hospital
Saratov, Russia
Tomsk Regional Clinical Hospital
Tomsk, Russia
Tula Regional Clinical Hospital
Tula, Russia
Clinical Hospital of Emergency Care named after N.V. Solovyev
Yaroslavl, Russia
Institute of Rheumatology
Belgrade, Serbia
Institute for Rehabilitation and Treatment Niska Banja
Niška Banja, Serbia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.